1-Methylpyrrolidine-2-methylamine → HCID 71715226, compound

HRID 575158

Reaction equation

HRID 575158 reaction equation
[C:1]([C:4]1[N:5]=[C:6]2[C:12]3[CH:13]=[C:14]([C:18]#[C:19][C:20]([OH:23])([CH3:22])[CH3:21])[C:15]([F:17])=[CH:16][C:11]=3[O:10][CH2:9][CH2:8][N:7]2[C:24]=1[C:25]([OH:27])=O)(=[O:3])[NH2:2].[CH3:28][N:29]1[CH2:33][CH2:32][CH2:31][CH:30]1[CH2:34][NH2:35]>>[F:17][C:15]1[C:14]([C:18]#[C:19][C:20]([OH:23])([CH3:21])[CH3:22])=[CH:13][C:12]2[C:6]3[N:7]([C:24]([C:25]([NH:35][CH2:34][CH:30]4[CH2:31][CH2:32][CH2:33][N:29]4[CH3:28])=[O:27])=[C:4]([C:1]([NH2:2])=[O:3])[N:5]=3)[CH2:8][CH2:9][O:10][C:11]=2[CH:16]=1

Participants

3

Reactant 2

HCID 1173001-Methylpyrrolidine-2-methylamineHCID 866931712-Carbamoyl-9-fluoro-10-(3-hydroxy-3-methyl-but-1-ynyl)-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepine-3-carboxylic acid

Product 1

HCID 71715226HCID 71715226, compound

Procedure

2-Carbamoyl-9-fluoro-10-(3-hydroxy-3-methyl-but-1-ynyl)-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepine-3-carboxylic acid (0.05 g) was reacted with (1-methylpyrrolidin-2-yl)methylamine similar to as described in Example 2 to afford 7.6 mg of (±) 9-fluoro-10-(3-hydroxy-3-methyl-but-1-ynyl)-N3-[(1-methylpyrrolidin-2-yl)methyl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepine-2,3-dicarboxamide following reverse phase hplc purification. MS (Q1) 470 (M)+. 1H NMR (400 MHz, DMSO) δ 8.58 (d, J=8.5 Hz, 1H), 7.74 (s, 1H), 7.27 (s, 1H), 7.01 (d, J=10.4, 4.6 Hz, 1H), 4.67-4.44 (m, 2H), 4.44-4.14 (m, 2H), 2.96 (s, 2H), 2.36 (s, 1H), 2.02-1.86 (m, 2H), 1.83 (s, 1H), 1.78-1.62 (m, 1H), 1.49 (s, 6H).

Sources & evidence

ORD record
ord-2a008b2c60b04d3d9ca9f5bb66dd3ed8
Source dataset
uspto-grants-2015_05
Patent number
US09034866B2

Linked notes

Loading…